Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If investors are foolish enough to push PUMO Biotechnology (PBYI)to over $100 in 2017, TLT's breakthrough cancer/virus cure/therapy is easily worth $20 to start. It could be worth that just for the melanoma application by itself. I mention PBYI b/c they are in the cancer treatment/cure space for breast cancer and NSCLC. So a competitor of sorts to TLT.
Watching this pps trade back and forth to the same groups, with minimal daily volume is laughable. As if we're not aware that a group of someones isn't suppressing the share price.
Time is all it takes to continue the progress and multiple applications for TLD1433 and all the rest. Stay patient my friends.
It's not a matter of if, but when this squeezes the shorts. Karma is a b!tch when it happens.
Happy New Year. Good luck to all. Regards,BK.
Saster, Our prayers and best wishes to you and your family. God speed for his recovery. Regards,BK.
Reply 121786 Livendy, There's no possibility of TMDI licensing the IP. The loan terms and conditions state exclusivity of the IP licenses. Let's not speculate any more about the endless banter about licensing IP for revenue. MDT isn't so dumb so as to not tie up the IP so it can't be shared, unless the loan is paid off or there is a change of ownership. I'm not sure if there's even an early payoff provision before the end of loan term. EOM.
Good luck to all. Regards,BK.
DRG, Interesting perspective. I like the process. How would you determine the FDA approved version share price? If MDT buys Titan pre-FDA, I'd think it wouldn't be for much less, b/c they wouldn't buy Titan unless they were sure the device was FDA approvable. TIA.
Happy New Year. Good luck to all. Regards, BK.
Timteo, That's a fair question. I think if we see consecutive and consistently higher volume trading then that would signal to me that "other" Wall Street types are digging into this partnership. That's also what Rollgard's message has been for months. There's been enough of high volume and buying consistently over the past 6-8 weeks that if anyone wants to short, they are really taking a HUGE risk. From what I've seen all dips have been bought up, and new raises established.
I can't be sure about anything else until we see or hear something of substance about ENOS or Titan strategic partner events. I've got nothing from which to substantiate my guesses, except for those elements that I feel are important, and fit my product development/launch parameters. And the small bits of information that is known, what's been said, and that which has not been said by Titan. And throw in a lot of selective omission.
Timing is a key launch parameter, and when I see more of HUGO then I'll know how those event details effect all of my other guesses.
Happy New Year. Good luck to all. Regards,BK.
DRG, I agree. The big question is "what's a huge premium?" And what's the basis share price from which to gauge the premium?
Something that did occur to me recently. Some of the basis for the NC HQ, and all of the R&D engineers would be for additional resources to draft, document and submit additional patents. The original Team Genova just didn't have enough horsepower to apply to the broad spectrum of the changes over the course of this past year and the new developments since the MDT projects.
You can't leave IP idly sitting on the table. IP is the gift that keeps on giving. Then drafting patent submissions would be critical. That fits in my mind b/c they wouldn't be actually building the prototypes - there's just not enough engineers to mock up and build them. That's a Cambridge job.
That said, now how much is TMDI worth? My guess is it's close to $38/share. And that amount is being validated more each passing day.
Good luck to all. Regards,BK.
Crossover, If you've read my posts then you know my crystal ball for guessing when is murky at best. As close as I'm able to guess would be sometime in 2021. There are too many variables. Most are based on which way the wind blows at MDT. And, if there's any likelihood of a competitor showing any interest, which could change the timeline.
I could possibly be more clear if we had ANY information about the content of the milestones. But, we don't.
There's a lot of guessing going on already, and much of it is really thin on substance. Yes, ColubrisMX is in the picture. However I'm still reluctant to claim any TMDI and ColubrisMX affiliation. It could be a question posed to Mc unless ColubrisMX is somehow included in the MDT projects. If not, then an answer from MC should be forthcoming b/c it may be a material event. IF there was an affiliation, then I'd say it would be b/c of an MDT interest, not specifically a TMDI initiated interest. But those scaled-down snake arms are a very interesting/enticing product. And for all of the previously viewed videos of ColubrisMX they were wristed with elbows and not linked snake arms - until recently. Hmmmm......
That's it - sometime in 2021. With caveats for competitors showing interest. But again, I'd really be surprised if MDT didn't already have so many hooks into Titan that there's no way for anyone else to play. The loan terms and conditions are just unnecessary with milestone payments, and the $18M offering requirements. So the "loan" sticks out as a major "what's this for?" event in my mind. It doesn't fit the situational awareness condition(s).
Good luck to all. Regards,BK.
Flenderson, What are you hearing in your neck of the woods?
Good luck to all. Regards,BK.
Crossover, It's over when you hear your bank account squeal b/c there's no more room for the money that's been stuffed in it, or your brain can't take the anxiety of hoping for more beyond what's already there. All good problems to have.
Happy New Year to all. Regards,BK.
Beast, don't be too concerned over that article in Motley Fool. It's intended to be an advertisement for the stock picks newsletter. Further, there was no objectivity in the comparison. Just here's the analysis on the history and actual numbers, blah, blah. Nothing about possible new developments with any of the RAS devices either company is selling. It's not research material. But, I appreciate your taking the time to look and share.
Today was a good example of the "other side" exercising their ability to drop us a few pennies, just to let everyone know they are still there and in the fight. It's a futile effort. B/c they couldn't stop the buying over the course of the past few weeks and won't going forward. It's a few malcontents vs wall street for a stock that has a proven path and the largest medical device company in the world as a partner. But, it's fun to poke at them anyway.
It's a $1.50 going to over $20. My guess is $38. Again, futile.
Good luck to all. Regards,BK.
OR Nurse (et al), All good questions, but this is all IMO. As a percentage of shares sold today by those that have a short-term view, say from $.50 and took profit and said good-bye - I'd guess 10%. And I'd seriously ask why at this stage in the development would anyone sell b/c there's a better than 50/50 chance this goes a lot higher as more Wall Street types start to dig into this partnership. Personally, I'm still buying a little here and there. It's $1.50. Even if I'm wrong and it's not $38, it's still a HELLofaLOT higher than $1.50...
Those that sold today for a short-term gain planing to get back in at a lower price sometime early next year - 5%. The reason I chose 5% for the volume for flippers would be b/c this stock has a long history, and a BIG majority of those that hold this stock feel strongly about the value of the IP. I'm in that group. And.....MDT is also in that group. The risk reward is far too high with MDT on the playing field.
I'm also in the group of those that bought too early and severely underwater. I take comfort in the fact that (IMO) - Mr. Martha views his reputation as significantly more valuable than my investment losses at this time. It's all situational awareness. So if he wants to polish that "I'm buying value" reputation, and he wants other companies to work with him in the future....then he will give fair value to the depth and level of unique features of our IP, and everyone is happy. If the BO deal is ugly, that's not good PR and other companies will view that takeover style as predatory. My view of "fairness" may be just worth nothing, but there is a thing called good-will. Either you think it exists in this partnership or it's too blue-sky and rainbows.
My only comfort is in the value of the IP, and the math. I have strong feelings that I'll get all of my investment back. And if my calculations/extrapolations/research is even close then $38/share is my best guess. More than that.... is payback for all of the anxiety caused by the delays, lying and BS. And I'm giving Mc the benefit of the doubt NOW, b/c I know he can't share the value and functionality of ENOS/SPORT.
I couldn't begin to determine knowing which is a shorter and which is an investor trying to cost-average down, except the trades that were for 100 shares or less. Those are shorters only looking to walk the share price down. I don't know of any paperboys spending their holiday tips buying TMDI stock.
Everyone else was buying and holding to take a bigger position, or dollar-cost-average b/c they are realistically admitting that they don't know when or how far this will go tomorrow.
Good luck to all. Regards,BK.
Someone or a group of someone's are selling (throwing away) a lot of shares at this price range to keep it from running. Hmmmmm..... Who and why would that happen?
I'm predicting a minimum of $38 a share BO. Could be more if it's a partial MDT stock swap. I'm not a fan of a stock swap, b/c share value IS inflated. If I want MDT stock after the BO, I'll purchase them on the OM. Unless MDT is throwing in a % for enticement to approve a BO as a sweetener. I'll let you know if/when they call me for my opinion.
The BO is going to happen. MDT NEEDS more horsepower to move higher. How else is Mr. Martha going to increase the MDT share price? Buy TMDI and immediately increase the value of the company by leveraging the IP across multiple platforms, AND increase the market cap by $X0B's within 3 years of BO. Where else are they going to capture near-term (within 24 months) expansion in RAS with a 20 year moat?
Sincerely, a Merry Christmas to all that I've had the pleasure to read and unfortunately unable to meet to have an adult beverage. Someday.
Good luck to all. Regards,BK.
SMIRZA seriously? You didn't just say that - right? I can't tell if your serious or just poking a few chosen poster's. Mc can't buy ANY shares b/c of undisclosed material events. Those events are confidential as the entire company and all it's assets (IP) are tied up as collateral for the loan. If you're joking, work on the funny parts please.
Good luck to all. Regards,BK.
Ok, I'll play. Please walk this down to sub-$.10 so I can pick up another 100K shares. TIA. Good luck to all. Regards,BK.
As I've mentioned before, once these shares get bought - most won't be coming back in the market. From what I've read we're nearly 100% in agreement that these shares are worth (far above) of $20 per share. Why sell at $1.50? That math makes my head hurt.
What's laughable is seeing so many trades at less than 100 shares, and many below 10 shares. The commission costs more than the total value of the purchase. Not my monkey.
One more time - just for the record. You're selling into a bottomless pit. Thank you to those willing to sell at these seriously undervalued prices. Good luck to all. Regards,BK.
Just Wow. Someone's just manipulating the hello ut of this stock. Accumulate for a few weeks, and then walk it down. Just BS.
Good luck to all. Regards,BK.
Reply 121115 Blast, I don't understand. I'm looking at the video that shows a distinct similarity, if not the exact functioning snake arms. It just took me be complete surprise. Am I imagining those?
Somebody clearly understands or knows something that which I'm not aware.
Good luck to all. Regards, BK.
Reply 121106 Pontiac, I'd say watching that video at 15:30 on to 16 would prove more informative. Somehow that video was taken in 2019, and those snake arms haven't been declared as a material event. Hmmm.
Good luck to all. Regards, BK.
Reply 121053 Parmmoney, good question. I base my statement on the fact that too many small share transactions daily are offered below the Ask, then lower bids show up. Stepping lower by pennies. Someone is selling into those lower bids, and too often and too regular. I don't think I'm incorrect by saying if the sellers would not sell below the ask, to fill a bid, and then move lower - the share price would be $2-$4 range. Personally I really expect that much of a move once we see the current version of ENOS.
What many don't seem to understand, is that the project agreements tie up any communication about ENOS, as to how far advanced the device has come compared to the last demonstration. By expecting a PR for every patent to come down the pike, it just invites prying eyes by the competition. We know the functionality. It's not going to change into a race car! I'm of the same opinion as others that have previously stated that software is being tested for triple redundancy and safety. I'll give Mc the benefit of the doubt and say he tried to get more $$$ up front, but MDT probably said "if we give you all that you want, then the share price will go to the moon." And it's too soon for where we are in the process of integrating your IP. Or something to that effect. I'm OK with that, if some version of that happened so long as we get $40M for next license agreement, and 2x for each extension of milestones beyond #4. The good news is they can't keep these projects in the closet for much longer. To the end of the 4th milestone tops on ENOS, unless they extend the milestones. Then if that happens - shareholders will have to demand some type of disclosure PRIOR to the AGM, or Mc will risk getting voted off the island. Of course Mc could delay the AGM for some BS reason.
I'm surprised to read all of the chatter about endo, b/c Mc has barely been able to put one foot in front of the other, and now some of our associates think he's managing ENOS, endo, and HUGO all at the same time???? Again, I hear my Statistics Prof in my ear. Possible, but highly improbable. As far as endo goes, the current version of ENOS could possibly be a close design if the boom can be lowered far enough to get into position. Now, I'm not saying the snake arms, and insertion tube are the correct size or the extension (length of reach) of the insertion tube and arms extend far enough. I really think the endo development is still early. And I think something happens prior to mid-next year with news, or disclosure about ENOS or the MDT partnership. Regardless of the NDA's, leaks occur. Wall Street has ears. THEY are greedy. It only takes a few to get into buying shares and then many others will notice. Hopefully.
I also don't see how ColubrisMX fits b/c while they have a prototype, our insertion tube and snake arms are too large. Unless they have a patent that would be beneficial to us, I think our stable of IP surpasses theirs by a wide margin. Dan Kim has jumped twice and it wouldn't surprise me to see him posturing for a merger of IP, or a position at TMDI. Pure speculation on my part.
Good luck to all. Regards, BK.
Reply 120992 Pharmmoney, I don't think MDT shareholders would care if this was $.50 a share knowing that this share price has been artificially suppressed so as to not reflect a more accurate share price commensurate with the value of the existing IP. And the value of that IP's abilities to defend the design(s) of ENOS and any future devices that which it may be incorporated.
Fair market value is all subjective. ISRG has a market cap multiple of 20x actual annual revenue. Takeover targets in biotech are all based on size of potential market, uniqueness of the drug application, ability to enter into alternate-use markets, and how desperate a competitor may be to keep the acquirer from finishing the acquisition.
I don't think this BO will be any different. I'd bet there will be an additional unknown issue/event thrown in for sheer terror, and the possibilities of real life events becoming actually stranger than fiction. I'll be happy to be wrong, and just make it a boring straight-up +$4B BO. (Personally, I think +$4B is very, very cheap. Considering the cost of development time, creativity, ability to navigate existing competitive IP, etc.). And if my math is correct $4B is closer to $32-$34 per share? I like your $40/share better. Someone please check my math and please feel free to correct those figures. As if I need to ask or extend an invitation??? Ha!
This may not be over when we think it's over. Life on the corporate battlefield will remain after this BO.
Good luck to all. Regards,BK.
Shorts, No question. There must have been 50-100 small lot buy/sells today. Can't confirm it but I'm guessing passing shares back-and-forth. I don't think this price action is fooling anyone, except perhaps those that think shares are done being accumulated. If I was the accumulator, I'd wait and jump in close to the low of the day. Rinse and repeat. It's up to whomever will buy a large amount again to drive the price above the current range.
Trying to time this has never worked for me. Just dollar cost average as long as the money holds out. If I could only remember where I buried those coffee cans in the backyard....
Good luck to all. Regards, BK.
Repy 120947 TimesYours, Good to hear from you. I can't make a prediction as you asked, b/c I don't have a lot of concrete information. I do base my opinions on educated assumptions, and I make sure everyone knows that they are my assumptions. I couldn't fathom a guess as to when/if a BO. I'm invested b/c I'm thinking it will be a BO. I'm thinking it would be in MDT's best interest to buy TMDI sooner than later b/c it would probably be less expensive. Unless Wall St types hear about it and go nuts over the share price. Or a competitor can insert themselves in the process. My sense is that MDT would do EVERYTHING in their power to keep that from happening. How they do it, is outside of my experience.
I do feel that the value is in question, and IMO all about awarded patents, and how desperate MDT may be to secure that design/IP. I'll defer to FaceTrain, Flenderson and Roll as they all have extensive experience. But I manage my expectations by telling myself this BO is unique to TMDI IP, the market and MDT needs. Many similarities to other BO's, but Mc has to know Martha isn't going to shower him with dollars out of the goodness of his heart. Though he should after seeing HUGO. Point for us if played correctly. I do agree with Rocko's recent post about competitor companies jumping in regardless of the provisions to back out of a deal, if MDT makes a low-ball offer.
I am concerned about Mc's ability to negotiate with Martha. He hasn't shown the shareholders much (OK none) of his abilities to really manage the financial end of this company until this most recent event with MDT. I do think this share price goes a lot higher once we/the general public get to see a video of the upgraded ENOS, with demonstrations of it's features. Once those are declared and shared there will be direct comparisons of ENOS to ISRG's SP. But, I would temper my enthusiasm only to the extent that it's like comparing 2 professional football teams. Both are in the pro league, but with different strengths. It will be highly entertaining to hear of those comparisons from the viewing public.
I've read recently that a board member thinks there's been a handshake agreement per se. I don't think that b/c that would be construed as a verbal contract, which is a required mandatory disclosure from Mc. I've said it several times before - he's walking a very fine line between developing future events and making future commitments. Again referring back to his fiduciary duties. This deal will be graded and reviewed by the investment community, and his reputation will be made (good or bad) from the outcome. That's his monkey.
I think there will be a lot of strongly worded questions posed to the BOD, once a BO is announced to confirm that Mc is getting the maximum value for the shareholders and not just negotiate a sweetheart deal to keep his job, as a part of MDT.
I wish I had a better answer. My logic of the circumstances would dictate sooner than later. And I do think based on my research of Titan's assets it's worth north of $4B. Now if Mc can just get us there.
Good luck to all. Regards, BK
Reply 120943 Rocko, I don't dispute that possibility of JNJ or ISRG getting into the bidding. But, from what I've read about the loan there's language that says all of Titan's IP is tied up as collateral, until paid off, change of ownership, etc.
If I were to write that loan language, I'd include a Right of First Refusal. And any IP that's developed during these milestones is co-owned with MDT. So it just depends on the loan language. Further, I would hope that there's an early payoff provision. See, nothing is clear.
I truly hope for everyone that there's a bidding war. Per FaceTrain and his experience (Post 114234), based on the RAS market projected size between now and 2028 - Titan could be worth +$4-$6B, at a minimum. And I agree with FaceTrains opinion about MDT already owning more than 25% of Titan at this time. They could have easily picked up that many shares, and spread them across subsidiaries to keep them below the 5% declaration limit. The additional bidding would be based on the degree of desperation from other players in the market that feel they need ENOS, or become irrelevant.
Mc better realize that this IP can be applied across multiple platforms, and leverage the unique characteristics. MDT has already done their due diligence. That confirms for me the value of this partnership. Now it's down to execution and total value. Mc has to negotiate on behalf of the companies shareholders, not to get a job at MDT.
Good luck to all. Regards,BK.
Pontiac, as my college statistics prof once told me regarding getting an A in his class: "Anything is possible, but THAT is highly improbable." IMO. Good luck to all. Regards, BK.
Repy 120919 Shorts..., You are correct from my perspective. I'd say the license agreement and the $18M raise was calculated for Titan operations, new US office, US engineers, additional R&D and additional work on ENOS. If I was planning these steps, I'd have the end game identified and the revenue either in hand, pending, or clearly delineated - with contingencies. Never have a plan A without a plan B. With as much distaste as there was displayed for a R/S, and Mc with a 51% approval rating - I'd speculate that the operating revenue has been firmly established, way past August 2021. Otherwise it would not have been prudent to establish as a U.S. based operation. Which is all confirmed by the length of the U.S.lease(s), the subsequent immediate expansion, and the soon-to-be expiration of the Canadian lease. I'd say the writing is on the wall for Mc to bring value to the plan before the next shareholders meeting. That's very good news for us. It's a solid, clearly defined date certain event.
I'm guessing the milestone payments were based/calculated on multiple sequential quote(s) from Cambridge to do the work MDT was proposing. Cambridge does all of the mfg. work from what I can tell. At least that's how I would have structured it, with a large additional percentage (cushion) factored in. That's not to say some of the work on ENOS won't continue at the same time. My hope is some of the MDT milestone development will also be incorporated into ENOS, so that work will be a "two-for," both for MDT and Titan. I just don't know.
While I value Mc and he has his name on a few patents.... Dr. Genova can carry the water. I think there's a place for Mc with MDT, b/c HUGO is not an elegant design and what ever resources are in-house at MDT are clearly all-in on HUGO. I have no idea if MDT has done any work on a SP, but what $150B company wouldn't have a 5 year plan? But if those are the same people that designed HUGO - then Titan would be my solution to move MDT forward quickly. And the IP must be compelling enough that MDT feels it's defensible against ISRG. Can you imagine the level of DD done on our IP? HUGO would scare the sh!t out of me if I was Martha. After seeing HUGO, truthfully I'd go for 2 ENOS. Hmmm?
This is all speculation on my part. It fits, but I may be wrong. Until someone can tell us the depth of what's in the milestones, and more importantly what details are in the loan and license agreements it's all IMO. There was language to increase the loan agreement, so I'm guessing that there are escalator clauses in the license agreement for newly minted IP. Hard to believe MDT would license design(s)/IP that are not approved by the U.S. Patent Office.
If anyone is wondering how Titan generates revenue going forward just look at the IP. IP is a 20 year moat. Reread FaceTrains emails about his experiences with IP and how it effects competition. I'm sure a lot of the IP will transition to the endoluminal version of ENOS, which one could argue would be additional leverage when calculating the value at the time of BO. I find the combination of Titan and MDT very compelling.
Sorry, the reply is long-winded. It's more than you asked for. I look at this little company from a lot of different angles, and the product, R&D and timing with MDT just fits.
Good luck to all. Regards,BK.
Share price and current state of affairs:
MDT Annual Shareholders Mtg - no mention of Titan, ENOS or development agreement. However, at approximately the 13 minute mark, a HUGO question was asked. The answer was: IDE submission to the FDA is anticipated sometime during the 1st calendar quarter of 2021, with CE at approximately the same time. Nothing more from MDT.
The content of the Titan/MDT development agreement(s) are still a mystery. I'm not aware of MDT developing a SP surgical robot, so I can only guess that our IP is being applied to HUGO. Anything available from anyone regarding the development would be welcome news on this board.
I offer this as food for thought. Someone's gobbling up shares as fast as those foolish enough to sell at these prices ($1.25-1.35). Logic tells me if it's a Wall St. type, they target big multiples. And my assumptions are just that, assumptions. Based on this level of interest, b/c TMDI's on the same path as was ISRG, but with what would appear on the surface to be a BIG partner. MDT has already declared their business model is to aggressively acquire tech. Which makes sense b/c they have a lot of cash, and only an MP robot at this time. Seems to be a very good fit sometime down the road.
I also looked at ColubrisMX. 2 RAS devices (SP and Endoluminal) and I question why didn't MDT work with them? Their videos are easy to find online to view their procedures. I can only conclude (without any evidence) MDT compared both, and ours was superior. Regardless of the fact that TMDI was "desperate" for cash, MDT would take the long-road and pick the best IP. Just my opinion. And these agreements take a long time to facilitate, and my guess is MDT had been talking with Titan much earlier in 2019.
I can't recall who on the board guessed that TMDI was worth about $10 a share, or about 1.2B? Please correct me if I'm remembering this incorrectly. My thoughts as a comparison are based on the time-value of money and the advantage of a leap forward to bring a SP product to market, as compared to starting from scratch. And the ability to defend the IP against any other competitor known at this time, I'd say the value is well north of $4B ($33-$34/share). That's just for the IP, b/c there will most likely not be any revenue from sales at the time of a BO. This is purely a guess, and I would ask anyone searching for better estimates to consider posts from FaceTrain, Flenderson, or offer a better source for further consideration by those on this board.
And finally, as of this past Thursday TMDI is no longer on the NASDAQ delisting list. We've traded over $1.00 for the past 10 days and are in compliance with membership guidelines. This was a bid distraction and a real pain-in-the-a$$ b/c shorters were using it for leverage. One less issue to deal with for at least another year. I don't disagree with the facts that Titan history has been near disastrous, but we have enough cash to work through next August, with what would appear to be a friendly partnership with the world's largest medical device company. I'm not a rainbows and blue-sky's investor, but feel very good about where we are in development, our working capital and abilities to raise more, and our vendor/development partnerships.
I offer this message b/c we're constantly searching for better information, and I know there are many new members reading this board. Every contribution is valuable, b/c we don't know what we don't know. Welcome. Good luck to all. Regards, BK.
Shhhhhh. Be vewey, vewey quiet. If we sneak up on $1.25 carefully...it will get bought. And go up again! Oh well, those shares won't get traded again. Rinse and repeat. Thank you. Good luck to all. Regards,BK.
I'm surprised. Clearly a group of someone's has been buying all of the offers at lower share prices, and those selling have not learned that they're just throwing their shares into bottomless pit.
With more than 30M shares purchased above $1.00, I'd think that those that bought them will not let their investment fade much. Seems like $1.25 is the happy purchase price. Just a guess.
I can only hope that it keeps up and we get rid of this senseless selling. If it were retail investors it would be mostly over by now. Who's that dumb?
Happy, happy, happy. Good luck to all. Regards, BK.
My editor informs me that I need to rewrite my script.
I'd say NO there's not enough market revenue for more than 1 daVinci MP, 1 daVinci SP and 1 HUGO (or whatever they finally call it). There that solves THE quest for research information once and for all. Here's a thought or two: At one time IBM thought that there was only a market for up to 5 large computers, and that was 4 too many. They were close. Microsoft purchased the rights to MS-DOS from SCP. So I'm looking at the RAS market like computers in the early days, and during the infancy of PC's/distributed computing. And MDT like Microsoft once they owned DOS. The ONLY way that happens again is due to the IP.
HINT: Trying to figure out Titan is a waste of time until we know what's in the development agreements. Which is why most of us are watching MDT closely. The development calendar had to be moved out at least a year b/c all of the ENOS engineering resources are currently committed to the MDT IP integration. Titan isn't building ENOS. They're designing, refining and enhancing 2.0, 3.0 etc.
For those that are having difficulty accumulating research material and keeping it in the forefront of their minds: This is the situational awareness part that seems to be missing each time you post. Please keep this post so you can read it every time you think to ask the same question(s) again. Happy to help.
Good luck to all. Regards, BK.
Reply 120622 Timberwolf, I don't care if you question my beliefs. My beliefs are not the "desired" beliefs. I've thought through this and lived it. You're just kinda questioning this, and questioning that. Just innocently posturing and so long as everyone knows it, so be it. I'm pretty sure many here already know the questions. You questioned the target and I provided "my" reasoning. Whether you care to agree, believe or not is your monkey.
Folks carping and whining have been here forever. They don't understand Mc can't buy stock in the present situation, but you hear it every week. Send a PR!!! MDT determines the communication. So, some are more patient and have better abilities to cope.
It's a message board. There are some really good people here, and the rest are part of the package. It's hard enough to swim in these "waters," without having someone pee in the pool. Comprender.
Good luck to all. Regards,BK.
Repy 120571 Timberwolf, why are you looking at numbers and disappointed? You're a self-proclaimed, experienced investor. Really, this is not a stock for you if you're looking at numbers. B/C TMDI is still in development. There will be no numbers that may lead you to conclude $10.00/share is reasonable. Personally, I think it will be very reasonable once we see this latest version in action. I think a lot of people are holding their collective breath - hoping it's all that and a bag-o-chips. That year-off target is based on the future value of a company that will be going down the same path as ISRG, but with 1 BIG difference. TMDI has a VERY BIG partner. I suspect that's why you're here at all. If anything... I question your situational awareness. They spend all the money they can get, and it's reflected in the quarterly statements. They have GREAT patents that are currently being licensed by the largest medical device company in the world. And.... more on the way. And... they are way ahead of any competition in development, and the only relevant device in the same discussion as ISRG.
What do you think will be the share price once MDT unveils their new version with TMDI IP? It's on its way, perhaps we see it in March or April. Both MDT and JNJ are stuck and can't use their current designs to compete with ISRG. TMDI is the "Little Engine That Could." That's what I want to be investing in. What else do you want???? Seriously. They have development agreements with MDT, and are receiving revenue instead of diluting. That's worthy of high praise. You'll find your entry point, I'm sure - but I'd ask where's your objectivity? Or is it objective? I'm not a Ra-Ra shareholder. I've been critical of past mistakes. I also don't claim to be smarter than anyone else, or think Mc is stupid, b/c I have no idea what's in those agreements. I've added 5K over the past 6 weeks, and I'll add more early next year. FWIW.
Glad your here, and looking forward to your opinions. Good luck to all. Regards, BK.
Reply 120500: Honey - I don't see a PR in the near future to support the SP. This run up started from nowhere, as $20M spent on over 15M shares with no news. I would guess that many here are not expecting news from TMDI b/c MDT is controlling the communication to the public. I would guess it's just basic supply and demand. When 15M shares are bought in a short period of time, the price will go up. The share increase appeared to be a controlled, calculated accumulation over many consecutive days. Possibly nothing more to it. Also, the buying started before the tax harvesting season. Why not wait? The timing, or lack-thereof is odd. Clearly I'm speculating. I don't think management is stupid, if there's no PR. IMO. Now, I do think who ever bought the 15M shares will defend the average purchase price. So with this much activity recently, I think we stay above $1, at least for the near term/late December. And it will be a fight with the artificial efforts to lower the sp by trading small lots back-and-forth between shorts. IMO. Good luck to all. Regards, BK.
Post 120274 Honey: I'll be generous and just say that if it takes more money to get to FDA, then MDT pays more for the IP next time. Personally, I'm disappointed the license agreement was only for $10M. Should have been for 2x or 3x that. Here's food for thought.
It's possible that Mc negotiated a future additional sum as soon as the next batch of patents is awarded. Once awarded, each makes the company more valuable and thus more $$$ for the next license agreement for more than $10M.
Why would MDT license IP, pay for milestones, use the IP to fix their multi-port and then leave TMDI to swing in the wind with a beautiful SP, nearly finished and better than anything known to exist for RAS? Oh! I know! So you can tell everyone management sucks and the sp goes lower so you can flip a few hundred shares. I can't believe you really write this BS every week (sometimes more than once a week) thinking people who read this board will believe you.
I don't know why, but a group of somebody's just spent more than $20M buying more than 15 million shares of TMDI over the past 10 days. Do really think they are going to let TMDI fail? Those "somebody's" know once they started to raise the SP it would attract more "shorts." So they have more $$$ in reserve to buy more shares on the dips. The share price may drift without news. Notice I said "may." I really don't think it moves much lower. But its only my opinion. And I'm not trying to scare anyone.
Your speculation had more credibility when we were at $.70 than now. Those "somebody's" are going to make sure that we go for 10 days to meet the NASDAQ requirement and put it behind us. IMO. It's a big distraction for Mc. I prefer TMDI focus on completing milestones and get on with finishing ENOS. And staying on the NASDAQ keeps TMDI on the radar for other whales once the sp goes to $3, or $4, or becomes a MOMO play. All the more reason for those "somebody's" to make sure it goes for 10 days. I suffer b/c I can't predict the future, but my deductive reasoning is pretty good.
The only reason ENOS isn't going further, or faster is b/c all of ENOS engineering resources are working on fixing/upgrading/modifying MDT's multi-port. With our IP integrated into MDT's bot it will become the predicate for our FDA submission. Or, MDT will own us by then. How many companies has MDT partnered with and then just let them go to a competitor? Haven't they done this more than 50-60 times? This "$h!t isn't easy." Just ask MDT. If you think Mc's a failure? Who's getting the blame over at MDT?
I'm not asking for you to give up your personal crusade - just stop with the chicken-little sky-is-falling BS. The act is stale and annoying. And by comparison MDT's robot project is far worse than ours. We have a money issue, not IP. They don't have a money issue and can't make it work/compete with ISRG. So where's MDT's money going to fix their BIGGER robot issues? That's just my perspective.
Good luck to all. Regards,BK.
Nice to see old friends around the campfire again. Good luck to all.
Regards, BK.
9 Days to go. It will be interesting to see how much volume will be bought up to the end of the 10th day. The volume today should have warned anyone about shorting, or selling at these levels. Someone, or a group of someone's are buying a ton. I'm guessing those "someone's" are not going to let this just drop back below $1. Just saying.
Rocko, I'm in compete agreement with your comments about ISRG and the sentiment held by potential new customers. The price for ENOS, as compared to daVinci will enable many new sites to do RAS sooner, than budgeting for a high(er) priced ISRG SP. I bring up price b/c I'd expect ISRG to lower theirs once ENOS is available.
Nice patents granted this week. That was a good chunk of IP that will keep the wolves away for a long time.
Good luck to all. Regards, BK.
Frank: Great music. Thank you. I'd like to make the suggestion that we mark that post as the theme to our investment. Good luck to all. Regards,BK.
Lakersback: Once FTA granted, the next steps are for the TMO to get 4-5 clinical site open to enroll and treat patients in U.S. Which was outlined the Q3 newsletter.
11.25.20 Per Stockhouse (V.TLT Bullboard)member FloatinKentucky: Theralase® is in advanced discussions to launch a number of U.S. based clinical study sites in 4Q2020, subject to the United States economy recovering from the COVID-19 pandemic. The U.S. based Trial Management Organization (“TMO”) plans to launch 4 to 5 clinical study sites in 4Q2020 and commence Study II patient enrollment and treatment as early as 1Q2021
3Q2020 QUARTERLY NEWSLETTER
https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=31969591
I'd say that pretty much sums it up.
Good luck to all. Regards,BK.
Roll, Slow Runner, et al: I've been noticing this for more than just last week and to me it's a direct indication that the share price is being suppressed purposely. Someone is putting on a show in an effort to make it obvious. It is. So now we can take this indication and apply it to the company situation, and partially understand their challenge with regard to an artificially low share price. This is not my way of making any excuses for lack of communication, or accuracy regarding time lines - or any other contributing factor that some on this board would attribute to terrible management. (Those of whom couldn't predict the future if they had a time machine). Could be shorts, could be another fund that's heavily invested in ISRG - regardless it's clear evidence of a strong opposing current, added to all the other challenges for completing ENOS. And someone will point out (who shall not be named) it is incompetence, and has been, and always will be, forever more. BS. Good luck and Happy Thanksgiving to all. Regards,BK.
Times Yours 118633: Great info. Per the article;
Risk and Uncertainty 03/24/2020
One of the key long-term risks to Intuitive Surgical is that competitors introduce a compelling alternative to da Vinci procedures, siphoning off some of Intuitive's growth opportunities and potentially reducing the profitability of its business. We are particularly curious about J&J's foray into robotic surgery (previously via a joint venture with Alphabet, but now solo). Little is known what the other industry giants are working on regarding soft tissue surgery, but their interest in this field alone is worth monitoring. Aside from competition, other factors could impede robotic surgery's rapid advancement. Robotic surgery has yet to establish itself as a good alternative to manual laparoscopy in certain procedures such as benign hysterectomy, as well as general surgery. As reimbursement doesn't distinguish between manual and robotic MIS, and robotic instrumentation costs more, hospitals are forced to eat the difference between the two procedures, and if clinical benefit isn't well established, manual laparoscopy may prevail. Finally, cost-conscious hospitals, particularly outside the United States, have been cautious in adopting da Vinci.
Yes, RAS is somewhat of a novelty, unless the hospitals can sell the benefits of "that" value proposition." They have to be able to justify the cost/benefits of that new instrument. I'd say a great deal of our headwinds are from existing large fund companies that are invested in ISRG. Why should they help us, if they're already committed to ISRG? MDT knows that the immediate market growth for multi-port is overseas. Let the games begin.
And for anyone that thinks we're not working to further develop ENOS/Sport - nothing could be further from the truth. The US HQ has a multi-year lease, and funding for at least another year. By my estimates for nearly 80 engineers. TMDI and product could continue to run from Canada, but has changed course. IMO.
Good luck to all. Regards,BK.
Reply 118489: MIRA, so we've spent as much as MDT and JNJ and have a viable design, with desirable IP based on the license agreement. The VI device is a "pogo-stick" compared to a rocket. I'd say your comment doesn't take into consideration the sophistication of the basic design of Sport/Enos which are the "multi-articulated" snake arms, and ease of changing end effectors. The Virtual Incision device would appear not to be able to change end-effectors without a complete removal of the entire device - far from ideal and not elegant. How Virtual Incision get's around the wristed end-effectors makes me curious.
You're actually helping me make my point, regardless of the cost of development. Thank you. If this device can be approved for IDE, we certainly can too.
Good luck to all. Regards, BK.